Directory · SE
Pharmaceutical Manufacturing in Sweden
A register of firms and the professionals working at them in the Pharmaceutical Manufacturing sector based in Sweden. Browse the public index, then filter or export on Kipplo.
Companies
280 on file
Lantheus
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in Canada and Sweden.
501 to 1000 staff
Apoteket Ab
Apoteket är Sveriges ledande apoteksaktör och ett av landets mest omtyckta varumärken. Kombinationen av lång historia, hållbart företagande och innovation,gör oss till ett dynamiskt företag där vi bidrar till ett liv i hälsa. Vi erbjuder ett brett utbud av läkemedel, noga utvalda hälsoprodukter och farmaceutiska tjänster till konsumenter och vården. Alltid tillsammans och mot ett gemensamt mål. Har du kunskap inom farmaci eller en passion för affärsutveckling? Är du teknikexpert, jurist, ekonomisk strateg, säkerhetskunnig, engagerad projektledare eller läkemedelsansvarig? Hos oss finns många möjligheter att växa och uvecklas. Oavsett vilken bransch eller roll du är verksam i idag hoppas vi att du blir nyfiken på oss.
1001 to 5000 staff
Immedica Pharma Ab
About Immedica Pharma Immedica is a pharmaceutical company, headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Welcome to the Immedica social media channels The Immedica social channels are set up to share news, updates, and company happenings with all visitors. Please note that postings by other visitors do not necessarily reflect the opinion of Immedica or confirm their accuracy. Immedica will routinely monitor comments and Immedica reserves the right to remove any posts that do not comply with our guidelines and to block anyone who violates them repeatedly. Examples of reasons for having a comment removed from a post on our social media might be- References a side effect or complaint - Reporting of an adverse event, side effect or reaction from an Immedica product (that information should be reported directly to Immedica Drug Safety or to your physician.)- A reference to a product or treatment We work in a highly regulated industry that does not allow us to engage with the public in discussions about products – ours or other companies – or treatment options. We never provide healthcare advice - your doctor or health care provider is the person to ask. If you have a product enquiry, please email the Immedica medical department- Abusive language We welcome your feedback, provided that you share your view in a way that is respectful to our community, meaning not inappropriate, off-topic, harassing, spamming in nature, or promoting/soliciting third-party sites, initiatives, or products Social media platforms may occasionally be unavailable, and we accept no responsibility for lack of service due to social media platform downtime.
51 to 200 staff
Doz Apotek
DOZ Apotek är Sveriges nyaste apotek men vår historia går långt tillbaka. Vi öppnade vårt första apotek i Eskilstuna 2010 under namnet Doc Morris och har sedan dess vuxit med etableringar. Idag har vi 74 fysiska apotek runtom i landet samt en komplett e-handel med ett stort e-handelsapotek beläget i Stockholm. Hos oss hittar du ca. 450 engagerade medarbetare men såklart även läkemedel och egenvårdsprodukter. Mellan 2013 – 2022 hittade du oss under namnet LloydsApotek men sommaren 2021 förvärvades LloydsApotek av CEPD N.V.(Corporation of European Pharmaceutical Distributors N.V.) som är ett internationellt holdingbolag och ett av de ledande företagen på Europas läkemedelsmarknad. CEPD förvaltar den femte största apotekskedjan i Europa och grundades 2008. CEPD är en erfaren och kunnig hälsovårdsaktör i Europa med huvudkontor i Amsterdam, Nederländerna. CEPD N.V.s mission är att förse kunder med apotekstjänster av högsta kvalitet och ett brett utbud av prisvärda produkter baserat på en innovativ och modern strategi för distribution och läkemedelsförsäljning. Under hösten 2022 lämnade vi namnet LloydsApotek till DOZ Apotek, namnet delar vi tillsammans med den femte största apotekskedjan i Europa med över 1300 apotek i Polen och Litauen. Begreppet DOZ kommer från det polska begreppet dbam o zdrowie, vilket betyder: Jag bryr mig om min hälsa.
501 to 1000 staff
Northx Biologics
Nestled in Sweden's life sciences heartland, NorthX Biologics has been at the forefront of biologics manufacturing and process development since 1992. Our rich heritage in Good Manufacturing Practice (GMP) is not just a testament to our enduring commitment to quality but also to the trust that the biotech community has placed in us for more than three decades. Our expertise within bioprocessing spans a variety of advanced modalities, including recombinant proteins, viral vaccines and cell therapy, supporting projects from concept through to commercial manufacturing offering a full spectrum of GMP-compliant services. It is our relentless pursuit of excellence and innovation that led to our recognition in 2021 as a national innovation hub for advanced therapeutics and vaccines by the Swedish Government, a milestone that underscores our role in shaping the future of healthcare. We are more than a CDMO; we are pioneers and partners in the truest sense. At NorthX Biologics, we believe in embarking on a collaborative journey with our clients, navigating the complexities of biologics and growing along the way. Let's journey together to turn visionary science into life-changing treatments. We specialise in: Process development Analytical development Recombinant proteins Virus & Vectors Cell Therapy Extracellular Vesicles Aseptic fill & finish Microbial & mammalian production QC, QA, QP
51 to 200 staff
Optimapharm
Optimapharm is a globally operating, leading, mid-sized, full-service CRO aiming to deliver new therapies to improve and save patients’ lives. Optimapharm’s key priorities are our people and consistently exceeding our client’s expectations. With 26 strategically located offices across Europe, Optimapharm gives unrivalled access to Patients and Investigators worldwide. In-depth expertise and long-standing experience, combined with a flexible and collaborative approach, allow optimization of design and planning; through its strong track record of delivery excellence and committed and stable project teams, Optimapharm has secured a high level of repeat business over the years. Companies Figures • 510+ staff members • Excellence in delivery and superior project performance with an investigator network of active sites • Close client relationship & high client retention rate of 85% • Highly educated workforce & low staff turnover rate; less than 15%, across the organization • Regional Cost-effective solutions Full-service study delivery, Stand-alone service and Functional Service Provider are the 3 pillars Optimapharm offers to best respond to planned clinical development and efficiently resource clinical projects. • Regulatory Affairs • Medical Affairs • Medical Writing • Clinical Monitoring • Project Management • Data Management • Biostatistics • Safety and Vigilance • Quality • Translation Services OPTIMAPHARM's offices- Austria - Belgium - Bosnia and Herzegovina - Bulgaria - Croatia - Czech Republic - Estonia - Finland - France - Georgia - Germany - Greece - Hungary - Lithuania - Republic of North Macedonia - Moldova - Poland - Romania - Serbia - Slovenia - Spain - Sweden - Switzerland - The United Kingdom - The United States of America
501 to 1000 staff
Astrazeneca
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit Community Guidelines: bit.ly/2MgAcio
10001+ staff
Gedeon Richter Nordics Ab
Gedeon Richter Nordics AB is a pharmaceutical company with a focus on gynecology and women's health. The company has 24 employees in the Nordic region and the Nordic headquarters is in Stockholm. Gedeon Richter Nordics AB is a wholly owned subsidiary of Gedeon Richter Plc with headquarters in Budapest, Hungary. The company is one of Eastern Europe's largest multinational pharmaceutical companies with research in gynecology, the central nervous system and the cardiovascular field. Through the purchase of Swiss PregLem, German Grünenthal women's health products and Swiss Finox, the company is expanding in Western Europe, primarily in gynecology.
11 to 50 staff
Iconovo Ab
Iconovo develops new inhaled medicinal products in collaboration with international pharmaceutical companies. We have several types of patented dry powder inhalers that can create significant commercial opportunities for the development of both new pharmaceuticals and generic medicine. Our strength is our inhouse capabilities with full control over both device development and formulation, meaning less risk and faster time to market.
11 to 50 staff
Keyplants
About us KeyPlants, headquartered in Stockholm, Sweden, is a leader in the off-site manufacturing space for the life science industry, having executed 100+ projects globally. Our customers benefit from KeyPlants’ vast experience and expertise, resulting in 30-50% shorter timelines and increased predictability with regards to schedule, cost, and quality. KeyPlants deliver pods and turnkey facilities including process equipment, utilities, and digital solutions.
51 to 200 staff
Apoex
ApoEx grundades 2010 i syfte att förenkla och förbättra vården. Sedan dess har tusentals vårdföretag inom privat och offentlig sektor valt ApoEx som sin strategiska partner avseende försörjning av läkemedel och förbrukningsmaterial. Verksamheten kännetecknas av kunddriven innovation och attityden att ingenting är omöjligt. Vill du utvecklas med oss? Läs mer om ApoEx på
201 to 500 staff
Apoteksgruppen
Från och med den 1 april 2025 har Apoteksgruppen gått samman med Kronans Apotek i ett och samma bolag. Följ oss vidare på Kronans Apotek för nyheter, jobbannonser och inspiration! https://karriar.kronansapotek.se/
1001 to 5000 staff
Kronans Apotek
Kronans Apotek är Sveriges största apotekskedja sett till antal apotek. Vi är närvarande i hela Sverige med våra närmare 500 apotek, en tillgänglig e-handel och drygt 3 500 medarbetare – så att du enkelt kan handla och få professionell rådgivning när det passar dig. Med kompetens, omtanke, tjänster och ett brett sortiment hjälper vi fler att må bättre och få ut mer av livet. 🧡
1001 to 5000 staff
Magle Chemoswed
We are a CDMO based in Malmö, Sweden, that serves companies in the pharmaceutical and medical device industry. We provide comprehensive services from development through manufacturing on a contract basis. Together with our partners, we take innovations from idea to product.
51 to 200 staff
Msd Sverige
MSD Sveriges officiella LinkedIn. Om oss: Frågor om MSD läkemedel: medicinskinfo@msd.com. Biverkansrapportering: pv.sweden@msd.com.
51 to 200 staff
Oncopeptides Ab Publ
Oncopeptides is a Swedish biotech company focusing on research, development and commercialization of targeted therapies for difficult-to-treat cancers. The company uses its proprietary Peptide Drug Conjugate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. Its flagship drug, Pepaxti, is currently being commercialized in Europe with partnership agreements for South Korea, the Middle East and Africa and elsewhere. Oncopeptides is also developing several new compounds based on its two proprietary technology platforms PDC and SPiKE. The company was founded in has about 80 employees with operations in Sweden, Germany, Austria, Spain and Italy. Oncopeptides is listed on Nasdaq Stockholm with the ticker ONCO. For more information, visit:
51 to 200 staff
Ondosis
We believe that everyone deserves a good life, and for some that is only possible when the medicine is just right. Therefore we are writing a new chapter in personalized medicine. OnDosis Dosage Manager delivers flexible and individualized dosing of oral medicines formulated as pellets, granules, mini tablets or powders. OnDosis is currently developing products for individualized dosing to help 100's of thousands of patients diseases with a significant unmet needs such as ADHD, food allergies, pain and immunosuppression for organ transplants. OnDosis was founded as a spin-out from AstraZeneca in 2017 and is headquartered at GoCo House in Gothenburg, Sweden.
11 to 50 staff
Sobi - Swedish Orphan Biovitrum Ab Publ
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.
1001 to 5000 staff
Vivesto Ab
Vivesto is a Swedish drug development company that aims to offer new treatment options for hard-to-treat cancers where there are major medical needs and significant market potential. The project portfolio consists of Cantrixil, which is being developed for blood cancer, and the veterinary oncology program Paccal Vet (paclitaxel micellar), which is being evaluated in a pilot clinical trial in dogs with splenic hemangiosarcoma following splenectomy and in a dose-finding study in cats with solid tumors. Vivesto’s shares are traded on Nasdaq Stockholm (ticker: VIVE). To find out more about Vivesto please visit
1 to 10 staff
Bluefish Pharmaceuticals
Founded in Sweden, with its long tradition of industrial entrepreneurship, Bluefish Pharmaceuticals has become one of the most progressive generics pharmaceuticals companies. At Bluefish, we strive to make quality medicines accessible to more people. We create value in the full pharmaceutical value chain from developing to manufacturing and successfully marketing generic pharmaceuticals and we take pride in doing this in an innovative, responsible and cost-efficient way. Bluefish currently conducts operations in 19 countries in Europe and, over the next few years, will also expand outside Europe with the aim of becoming a global player. Our corporate culture and close collaboration with development and manufacturing partners are integral parts of our effort to deliver quality products at affordable prices. We offer a product portfolio consisting of a broad range of high quality generics for all major therapeutic areas. It is part of our long-term strategy to expand the product portfolio of off-patent blockbusters while at the same time offering a broader range of niche products within more narrow disease areas.
51 to 200 staff
Diamyd Medical
Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for the prevention and treatment of autoimmune diabetes. The investigational flagship product Diamyd® is a disease-modifying antigen-specific immunotherapy for the preservation of endogenous insulin production that has Orphan Drug Designation in the U.S. and has been granted Fast Track designation by the U.S. FDA. DIAGNODE-3, a confirmatory Phase trial is actively recruiting patients with recent-onset Type 1 Diabetes in eight European countries and in the U.S. Diamyd Medical’s shares are traded on Nasdaq First North Growth Market, ticker DMYD B.
11 to 50 staff
Medivir Ab
Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates are directed toward indication areas where available therapies are limited or missing and there are great opportunities to offer significant improvements to patients. Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a smart, targeted chemotherapy designed to selectively treat liver cancer cells and to minimize side effects. Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership. Medivir's share (ticker: MVIR) is listed on Nasdaq Stockholm's Small Cap list.
1 to 10 staff
Niconovum Ab
Niconovum was formed in by Dr. Karl Olof Fagerström, one of the world’s leading experts on smoking cessation and nicotine dependence. Niconovum believes there is a need for a range of Nicotine Replacement Therapy (NRT) products that deliver nicotine efficiently and pleasantly – giving consumers better options to choose from in order to meet their personal tobacco reduction goals. Niconovum currently markets NRT products under the Zonnic brand in Sweden, Norway, Finland and Iceland. In 2009, Niconovum was acquired by Reynolds American Inc.(RAI) and in 2017, RAI was acquired by British American Tobacco (BAT). BAT has a stated ambition to lead the transformation of the tobacco industry by offering adult consumers a range of potentially reduced-risk products.
11 to 50 staff
Cambrex Karlskoga Ab
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides comprehensive analytical and IND enabling services, as well as drug substance development and manufacturing across the entire drug lifecycle. With over 40 years of experience and a team of experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API development and manufacturing.
201 to 500 staff
Chiesi Nordic
Chiesi is an international, privately-owned pharmaceutical company with its Corporate Head Office based in Parma, Italy. Chiesi is dedicated to the research, development and sales of innovative, therapeutic prescription medicines in the fields of respiratory, neonatology, transplant medicine and rare diseases. Founded in 1935, as a family firm, today, Chiesi spans the globe, employing more than people in 26 affiliates worldwide and distributes its products in more than 70 countries. In the Nordics, Chiesi Pharma AB employs more than 50 dedicated employees, who are based out of our head office in Central Stockholm, the recently integrated Research and Development Centre at Lidingö outside Stockholm or are part of our experienced field-based sales teams. As with every part of the Chiesi group, we embrace a shared set of values and a common code of ethical conduct. This demands the highest standards of reliability, transparency, and individual accountability in everything we do. It emphasizes the importance of collaborative working, putting people first and exchanging knowledge. Implicit in all of these values is a responsible attitude to the social and environmental impact of our actions. Chiesi is entering important new therapy areas, such as organ transplantation and rare diseases, alongside our treatments for respiratory conditions.
51 to 200 staff
Mcneil Ab I Helsingborg
McNeil AB är ett ledande läkemedelsföretag som tillverkar Nicorette-produkter för den globala marknaden. Våra produkter – som finns i över 80 länder – hjälper människor världen över att sluta med tobak och leva hälsosammare liv. Förutom tillverkning har vi även en global enhet för forskning och utveckling som arbetar inom tre områden: Smoking Cessation, Digestive Health samt Cough & Cold, Vi finns i Helsingborg och med cirka 650 medarbetare är vi ett av regionens största företag. McNeil AB är en del av Johnson & Johnson, ett av världens ledande hälsovårdsföretag med cirka 130 medarbetare världen över.
501 to 1000 staff
Nextmune
Nextmune is a science-driven, global specialty pharmaceutical company dedicated to better health for dogs, cats and horses. We have a passion for allergy, dermatology and specialized nutrition. Our business is at the forefront of allergy diagnostics and immunotherapy.
51 to 200 staff
Srs - Scandinavian Regulatory Services Ab
Scandinavian Regulatory Services AB (SRS) is a Swedish consultancy company founded in 1992. We offer regulatory expertise and services to the pharmaceutical, medical device and associated industries. SRS provides expert regulatory and quality support to bring generic and well-established pharmaceuticals, medical devices, cosmetics and food supplements to the market. We are a team of pharmaceutical and medical device regulatory affairs and quality systems specialists with extensive experience from all different aspects of regulatory affairs and quality covering a wide range of products. All consultants have long-term experience in the field, in leading and executing positions in international pharmaceutical and medical device industries and from regulatory authorities. Many of our clients are recurring clients and SRS is appreciated for the experience, knowledge and turnaround time.
11 to 50 staff
Agb-Pharma Ab
AGB-Pharma är ett svenskt nischat läkemedelsföretag med ett 25-tal anställda i 5 länder och med fokus på det naturliga sömnhormonet melatonin och behandling av sömnstörningar. AGB-Pharma verkar för att förbättra behandlingsvägarna för alla patienter som lever med sömnstörningar och att vara vårdens primära partner inom sömnhälsa. Företagets första produkt för barn med ADHD och sömnstörningar lanserades under 2021 i Skandinavien och idag är AGB-Pharma verksamt i Sverige, Norge, Danmark, Storbritannien, Tyskland och Frankrike med egen produktion i Skandinavien.
11 to 50 staff
Cinclus Pharma
Cinclus Pharma develops small molecules for the treatment of gastric acid related diseases. GERD is a digestive disorder causing retrograde flow of gastric juice into the esophagus. This leads to erosions, acid regurgitations and heartburn. Cinclus Pharma was founded by pioneers in GERD treatment, both with extensive experience from Astra and AstraZeneca, where clinical phase I and phase II studies were performed on the product candidate linaprazan. Together with the team at Cinclus Pharma the founders are now taking the development of linaprazan glurate to the next level. Cinclus Pharma’s lead drug candidate, linaprazan glurate, represents a novel class of drugs; Potassium Competitive Acid Blocker (P-CAB). A P-CAB is a fast-acting regulator of intragastric pH by a different mechanism of action than PPIs. Linaprazan glurate is firstly being developed for treatment of Gastroesophageal reflux disease (GERD), clinical studies are ongoing. Linaprazan glurate has the potential to alleviate GERD symptoms and heal esophageal injuries more effectively than current pharmaceutical therapies. Cinclus Pharma is preparing for a growth journey, gathering a motivated and competent team, working closely together in realizing our strategy. Sweden is the origin of many famous global biotech innovations and successful companies. Based in Stockholm, Cinclus Pharma has a unique opportunity to level up this heritage by combining experience and contemporary science with a competent and decisive board and management. Being a clinical stage pharma company, the clinical development of linaprazan glurate is at the core of the company’s growth. Read more about the scientific progress and product development strategy at our website.
1 to 10 staff
Gesynta Pharma Ab
Gesynta Pharma is a clinical-stage pharmaceutical company developing innovative treatments by targeting mPGES-1*, an important pro-inflammatory enzyme with a key role in endometriosis. Gesynta Pharma's research originated at Karolinska Institutet in Sweden. The company's leading compound, vipoglanstat, is a selective mPGES-1* inhibitor being developed as a new non-hormonal, non-opioid treatment with disease-modifying potential. Vipoglanstat is currently in Phase 2 clinical trials for endometriosis - a painful, chronic inflammatory disorder affecting about 10% of women of reproductive age. The condition often leads to a markedly reduced quality of life, particularly as many existing treatments fail to provide adequate symptom relief. Vipoglanstat has shown potent mPGES-1 inhibition and a favorable safety profile across Phase 1 and 2 clinical trials. Furthermore, a preclinical proof-of-concept study in an advanced model of endometriosis demonstrated that vipoglanstat significantly reduced pain-related behaviors and endometriotic lesions. A second drug candidate in the Gesynta Pharma portfolio, GS-073, is ready to enter clinical Phase 1 for the treatment of chronic inflammatory pain. The company's shareholders include Hadean Ventures, Industrifonden, Innovestor Life Science, Linc, HealthCap, XGen Venture, and other internationally renowned specialist investors.*mPGES-1: microsomal Prostaglandin E Synthase-1
1 to 10 staff
Medartuum Ab
Medartuum är en ledande aktör på den svenska marknaden för parallelldistribution av läkemedel. För mer information vänligen besök:
11 to 50 staff
Moberg Pharma Ab
Moberg Pharma AB (publ) är ett svenskt läkemedelsbolag med fokus på kommersialisering av egenutvecklade läkemedel baserade på beprövade substanser. Bolagets tillgång MOB-015 är en ny utvärtes behandling av nagelsvamp. Kliniska fas 3-studier av fler än 800 patienter för MOB-015 indikerar att produkten har potential att bli den framtida marknadsledaren inom nagelsvamp. Moberg Pharma har avtal med kommersiella partners på plats i bland annat Europa och Kanada och bolagets målsättning är att få första marknadsgodkännande och påbörja lansering av MOB-015 under 2023. Moberg Pharma har huvudkontor i Stockholm och bolagets aktie är noterad under Small Cap på Nasdaq Stockholm (OMX: MOB).
11 to 50 staff
Scandinavian Biopharma
We are a research-based specialty biopharma company determined to give people all over the world a longer and better life. We are developing the first vaccine for protection against diarrhoea caused by ETEC in both travellers and endemic populations. We distribute a wide range of specialty biopharma products with focus on vaccines and immunoglobulins.
11 to 50 staff
Scilifelab Drug Discovery & Development
SciLifeLab is the national Swedish academic drug discovery infrastructure. Our mission is to help turn academic discoveries into innovations. We also work to promote state-of the art drug discovery & development expertise in Sweden, and are open to global collaborations and partnerships.
51 to 200 staff
Avia Pharma Ab
We work in the most important field there is – health. Health is fundamental in order to experience and enjoy all aspects of life. It is with this strong conviction that our company was founded in 2016 by senior executives from the pharmaceutical and pharmacy industry. Since our inception, we have experienced rapid growth both organic and through aquisitions. Our operations nowadays span across Northern Europe, with offices in Stockholm, Helsinki, Munich and Greven, having a focus on five therapy areas: women’s health, urology, dermatology, allergy and everyday healthcare.
51 to 200 staff
Campuspharma
CampusPharma AB is a Swedish Pharmaceutical company which focuses on registration and marketing of medicines and medicine-related products in the Nordic countries. The business, which started in 2004, has developed strongly in recent years with a number of new medicines having been introduced. CampusPharma’s business concept is to market and sell unique medicines and medicine-related products on the Nordic market within the therapy areas that see to the needs of small and large patient groups. We focus on Women’s Health, Unlicensed Medicines and Special Pharma (niche products).
11 to 50 staff
Ipharmed Services
iPharMed, a European based service-oriented company offering regulatory solutions for Pharmaceuticals and Medical devices. Founded by a team of professionals with three decades of experience in the Pharm and Med Device industry. iPharMed will support beyond commitment and delivering Regulatory Services with flexibility, quality, speed with cost effective model. iPharMed effectively uses its infrastructure and talent to reduce the product registration time and also maintaining the post approval regulatory compliance. We are specialised in the Pharmaceuticals (CMC, eCTD and Pharmacovigilance) and Medical Devices (CER, BER, CE, 510(K) and PMS) area where we can provide complete End to End support iPharMed will help clients in the areas like IP, R&D, Quality, Sourcing of API & Products, Cosmetic and Consumer product registrations.
1 to 10 staff
Neogap Therapeutics Ab
NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden. Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system. Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy.
11 to 50 staff
Oblique Therapeutics Ab Publ
Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need with an internal pipeline focusing on pain. The company uses Abiprot®, a proprietary, next-generation antibody platform to identify accessible epitopes for antibody development.
1 to 10 staff
Svensk Dos
Svensk Dos is one of three dose providers in the Swedish market for dose dispensing to non-institutional care. At our company, pharmacists, operators, and support functions work to ensure a safe and reliable service for our customers.
51 to 200 staff
Viatris Connect Sverige
Vi på Viatris tillgodoser hälso- och sjukvårdens behov idag och i framtiden. Vi vågar utmana och drivs av en vilja att göra det rätta. Genom vår unika ställning bidrar vi med trygghet i en värld där behoven inom hälso- och sjukvården ständigt förändras.
10001+ staff
Zozium
We simply believe in Zozium, the latin word for partnership. Why? Because inside our walls, the partnership between our co-workers and customers shines through the entire business. We have years of experience in working within our business and offer engineering competence in quality, project management, leadership and technology development. Our partnership began in 2017 with a simple aim: To revolutionize the professional services market with a great package for our co-workers and access to a great range of competencies for our customers. We call it Zozium because this way, everyone wins. Get in touch with us at info@zozium.se
11 to 50 staff
E-Vis Swedish Medicines Verification Organisation
e-VIS provides an e-verification system that prevents falsified medicines from reaching patients via pharmacies or healthcare. The secure system helps ensure that every patient in Sweden can be confident the medicine they receive is genuine. e-VIS is supported by industry organisations within the entire medicine supply chain
1 to 10 staff
Eql Pharma Ab Publ
EQL Pharma AB (publ) is a pharmaceuticals company based out of Skåne County, Sweden.
11 to 50 staff
Galderma
Galderma is the leading company solely dedicated to skin and advancing the future of dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
5001 to 10000 staff
Intervacc Ab
A new generation of vaccines within animal health We develop vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care, with a very good safety profile.
11 to 50 staff
Lokon Pharma Ab
LOKON PHARMA is a Swedish biotech company in the forefront of developing immunostimulatory gene therapy for cancer-based on oncolytic viruses. Innovative gene engineering, solid expertise in cancer biology and immunology, as well as a genuine curiosity in life science expand Lokon’s pipeline towards groundbreaking new therapeutics for patients with high unmet medical need.
11 to 50 staff
